Bardou-Jacquet E - Search Results

1

Consensus Statement on the definition and classification of metabolic hyperferritinaemia.

Valenti L, Corradini E, Adams LA, Aigner E, Alqahtani S, Arrese M, Bardou-Jacquet E, Bugianesi E, Fernandez-Real JM, Girelli D, Hagström H, Henninger B, Kowdley K, Ligabue G, McClain D, Lainé F, Miyanishi K, Muckenthaler MU, Pagani A, Pedrotti P, Pietrangelo A, Prati D, Ryan JD, Silvestri L, Spearman CW, Stål P, Tsochatzis EA, Vinchi F, Zheng MH, Zoller H. Valenti L, et al. Among authors: bardou jacquet e. Nat Rev Endocrinol. 2023 May;19(5):299-310. doi: 10.1038/s41574-023-00807-6. Epub 2023 Feb 17. Nat Rev Endocrinol. 2023. PMID: 36805052 Free PMC article. Review.

2

Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.

Desgrippes R, Lainé F, Morcet J, Perrin M, Manet G, Jezequel C, Bardou-Jacquet E, Ropert M, Deugnier Y. Desgrippes R, et al. Hepatology. 2013 May;57(5):1784-92. doi: 10.1002/hep.26261. Epub 2013 Apr 4. Hepatology. 2013. PMID: 23322654

3

Long-term course after initial iron removal of iron excess in patients with dysmetabolic iron overload syndrome.

Bardou-Jacquet E, Lainé F, Morcet J, Perrin M, Guyader D, Deugnier Y. Bardou-Jacquet E, et al. Eur J Gastroenterol Hepatol. 2014 Apr;26(4):418-21. doi: 10.1097/MEG.0000000000000058. Eur J Gastroenterol Hepatol. 2014. PMID: 24557330

4

Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis.

Legros L, Bardou-Jacquet E, Latournerie M, Guillygomarc'h A, Turlin B, Le Lan C, Désille Y, Lainé F, Moirand R, Brissot P, Deugnier Y, Guyader D. Legros L, et al. Liver Int. 2015 Jun;35(6):1731-8. doi: 10.1111/liv.12762. Epub 2015 Feb 4. Liver Int. 2015. PMID: 25495562

5

Reply to: "Reduced mortality due to phlebotomy in moderately iron-loaded HFE Haemochromatosis? The need for clinical trials".

Bardou-Jacquet E, Lainé F, Deugnier Y. Bardou-Jacquet E, et al. J Hepatol. 2015 Jul;63(1):283-4. doi: 10.1016/j.jhep.2015.03.030. Epub 2015 Apr 1. J Hepatol. 2015. PMID: 25841362 Free article. No abstract available.

6

Both hepatic and body iron stores are increased in dysmetabolic iron overload syndrome. A case-control study.

Jézéquel C, Lainé F, Laviolle B, Kiani A, Bardou-Jacquet E, Deugnier Y. Jézéquel C, et al. PLoS One. 2015 Jun 1;10(6):e0128530. doi: 10.1371/journal.pone.0128530. eCollection 2015. PLoS One. 2015. PMID: 26030828 Free PMC article.

7

Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.

Lainé F, Ruivard M, Loustaud-Ratti V, Bonnet F, Calès P, Bardou-Jacquet E, Sacher-Huvelin S, Causse X, Beusnel C, Renault A, Bellissant E, Deugnier Y; Study Group. Lainé F, et al. Hepatology. 2017 Feb;65(2):465-474. doi: 10.1002/hep.28856. Epub 2016 Nov 10. Hepatology. 2017. PMID: 27685251 Free article. Clinical Trial.

8

Reply.

Lainé F, Bardou-Jacquet E, Paisant A, Gandon Y, Deugnier Y. Lainé F, et al. Hepatology. 2017 Jun;65(6):2119-2120. doi: 10.1002/hep.29032. Epub 2017 Apr 18. Hepatology. 2017. PMID: 28066931 No abstract available.

9

Is room temperature susceptometer really an accurate method to assess hepatocellular iron?

Paisant A, Lainé F, Gandon Y, Bardou-Jacquet E. Paisant A, et al. J Hepatol. 2017 Dec;67(6):1345-1346. doi: 10.1016/j.jhep.2017.07.021. Epub 2017 Aug 5. J Hepatol. 2017. PMID: 28789881 Free article. No abstract available.

10

Dysmetabolic iron overload syndrome (DIOS).

Deugnier Y, Bardou-Jacquet É, Lainé F. Deugnier Y, et al. Presse Med. 2017 Dec;46(12 Pt 2):e306-e311. doi: 10.1016/j.lpm.2017.05.036. Epub 2017 Nov 21. Presse Med. 2017. PMID: 29169710 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page